Today

Agents

Chat

Arena

Discover

More

App

Dorman Products Q2 Adjusted EPS USD 3.08 Vs. IBES Estimate USD 1.91 - DORM News | Rallies

Dorman Products Q2 Adjusted EPS USD 3.08 Vs. IBES Estimate USD 1.91

DORM•2026-08-03

Second-quarter results

Aug. 03 (Reuters) - Dorman Products Q2 EPS USD 2.93.

Q2 sales USD 544.6 million vs. IBES estimate USD 582.2 million

Related News

Vivos Therapeutics names Roman Franklin CFO as Bradford Amman resigns

VVOS•2026-08-03

Broadway Financial files Form 3 for EVP, Chief HR Officer Brian Francis Wagner

BYFC•2026-08-03

Venu Holding issues warrants for up to 1,000,000 shares alongside $25 million convertible debentures

VENU•2026-08-03

TransDigm files Form 3 for director Irina Krasik, reporting no beneficial ownership

TDG•2026-08-03

Citizens Financial declares quarterly Series E preferred dividend of $0.31 per depositary share

CFG•2026-08-03